Name (Synonyms) | Correlation | |
---|---|---|
drug949 | EHR-based Clinician Jumpstart Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D016491 | Peripheral Vascular Diseases NIH | 0.71 |
D058729 | Peripheral Arterial Disease NIH | 0.58 |
D014652 | Vascular Diseases NIH | 0.58 |
D009362 | Neoplasm Metastasis NIH | 0.50 |
D008103 | Liver Cirrhosis, NIH | 0.50 |
D051437 | Renal Insufficiency, NIH | 0.45 |
D008175 | Lung Neoplasms NIH | 0.45 |
D007676 | Kidney Failure, Chronic NIH | 0.38 |
D029424 | Pulmonary Disease, Chronic Obstructive NIH | 0.35 |
D006333 | Heart Failure NIH | 0.33 |
D017563 | Lung Diseases, Interstitial NIH | 0.29 |
D002908 | Chronic Disease NIH | 0.29 |
D008171 | Lung Diseases, NIH | 0.24 |
D009369 | Neoplasms, NIH | 0.21 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0001395 | Hepatic fibrosis HPO | 0.50 |
HP:0004950 | Peripheral arterial stenosis HPO | 0.45 |
HP:0000083 | Renal insufficiency HPO | 0.45 |
HP:0100526 | Neoplasm of the lung HPO | 0.45 |
HP:0006510 | Chronic pulmonary obstruction HPO | 0.35 |
HP:0001635 | Congestive heart failure HPO | 0.33 |
HP:0006515 | Interstitial pneumonitis HPO | 0.29 |
HP:0002088 | Abnormal lung morphology HPO | 0.24 |
HP:0002664 | Neoplasm HPO | 0.21 |
There is one clinical trial.
This is an observational, prospective, non-randomized, non-significant risk study collecting voice recordings from subjects who are being tested for COVID-19 by laboratory analysis of specimens obtained by nasal or naso-pharyngeal (NP) swab. Patients record their voices through an app on their mobile phone. Patients and health care providers will be blinded to the swab test results during Phase 2 of the study.
Description: compare Sensitivity and Specificity to standard swab test
Measure: Sensitivity and Specificity Time: 6 months